Skip to main content
. 2020 Aug 18;16(Suppl 1):3–9. doi: 10.1007/s11420-020-09779-z

Table 6.

Pharmacologic treatment during HSS admission

Overall COVID floor admit COVID ICU admit Other admit
N 148 111 19 18
Hydroxychloroquine (%) 7 (4.7) 5 (4.5) 0 (0.0) 2 (11.1)
Tocilizumab (%) 4 (2.7) 1 (0.9) 2 (10.5) 1 (5.6)
Remdesivir (%) 4 (2.7) 1 (0.9) 3 (15.8) 0 (0.0)
Convalescent plasma (%) 6 (4.1) 3 (2.7) 3 (15.8) 0 (0.0)
IVIG (%) 4 (2.7) 2 (1.8) 2 (10.5) 1 (5.6)
Vasopressors (%) 23 (15.5) 2 (1.8) 15 (78.9) 6 (33.3)

IVIG intravenous immunoglobulin